The genetic data industry is broken—big corporations profit from consumer DNA while individuals have no control or financial benefit from their most personal asset. This company is changing the game with a blockchain-secured platform that gives people full ownership of their genetic data, allowing them to monetize it on their terms while providing researchers access to high-quality, precision-selected genomic data.
Unlike existing DNA platforms that exploit user data with hidden terms and zero transparency, this company’s decentralized AI-driven approach ensures privacy, security, and direct profit-sharing for individuals. Researchers also benefit from granular control over data selection, enhancing research efficiency and scientific breakthroughs.
With a $40B+ market opportunity, rapidly increasing demand for high-quality genomic data, and growing public distrust in centralized DNA testing services, the company is positioned to disrupt the space. Currently raising funds to accelerate commercial launch, this is a rare chance to invest early in the future of ethical and secure genetic data monetization.
View the deck through the link below. Some unique identifiers have been removed. For access to detailed materials, please reach to us or your point of contact, as full decks are only shared upon request to maintain confidentiality and exclusivity.
View Pitch Deck